1. Duan, Jicheng, Qian, Youwen, Fu, Xiaohui, Liu, Chen, Chang, Yanxin. 2021. TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma. In Aging, 13, 5585-5606. doi:10.18632/aging.202487. https://pubmed.ncbi.nlm.nih.gov/33591950/
2. Meng, Yan, Zhou, Rulin, Lin, Zhizhao, Guo, Xuxue, Zhuang, Kangmin. 2022. Identification and Validation of a Novel Prognostic Gene Model for Colorectal Cancer. In Computational and mathematical methods in medicine, 2022, 9774219. doi:10.1155/2022/9774219. https://pubmed.ncbi.nlm.nih.gov/35924107/
3. Luo, Xi, Han, Gang, Lu, Renfei, Shao, Jianguo, Bian, Zhaolian. 2020. Transmembrane protein 106C promotes the development of hepatocellular carcinoma. In Journal of cellular biochemistry, 121, 4484-4495. doi:10.1002/jcb.29678. https://pubmed.ncbi.nlm.nih.gov/32037603/
4. Li, Jian-Di, He, Rong-Quan, Dang, Yi-Wu, Du, Xiu-Fang, Chen, Gang. . Unveiling expression patterns, mechanisms, and therapeutic opportunities of transmembrane protein 106C: From pan-cancers to hepatocellular carcinoma. In World journal of gastrointestinal oncology, 17, 92437. doi:10.4251/wjgo.v17.i2.92437. https://pubmed.ncbi.nlm.nih.gov/39958559/
5. Wei, Jianming, Wang, Bo, Gao, Xibo, Sun, Daqing. 2021. Prognostic Value of a Novel Signature With Nine Hepatitis C Virus-Induced Genes in Hepatic Cancer by Mining GEO and TCGA Databases. In Frontiers in cell and developmental biology, 9, 648279. doi:10.3389/fcell.2021.648279. https://pubmed.ncbi.nlm.nih.gov/34336819/